← Back
Data updated: Mar 29, 2026
WAYLIS THERAP
OncologyCardiovascularInfectious Disease
Big Pharma
WAYLIS THERAP is a major pharmaceutical company focused on Oncology, Cardiovascular, Infectious Disease.
1954
Since
15
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ADAPALENE 2024-08-26
Labeling
THIOGUANINE 2024-07-09
Labeling
DROXIA 2024-06-20
Labeling
ADAPALENE 2024-06-17
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
4 drugs
Cardiovascular 25%
2 drugs
Infectious Disease 13%
1 drugs
Gastroenterology 13%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease